ADIA Adia Med, Inc.

Fundamentals / CIK 0001160420 / USD

Adia Med, Inc. reported $1.20M in revenue and a net loss of $498K for the trailing twelve months ended September 30, 2026 (up 36.8% year over year), with a 35.3% gross margin and a -38.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ADIA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

2 fiscal years (2024 to 2025), reported in USD.

$732K$366K$0-$429KFY 2024 Revenue: $6.4KFY 2024 Net Income: -$181K2024FY 2025 Revenue: $701KFY 2025 Net Income: -$395K2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31
Revenue $701K $6.4K
Cost of Revenue $509K $4.2K
Gross Profit $192K $2.2K
Research & Development $29K $0
Total Operating Expenses $558K $177K
Operating Income -$366K -$175K
EBITDA -$362K -$174K
Interest Income $625 $0
Interest Expense $32K $6.3K
Income Before Tax -$395K -$181K
Income Tax Expense $0 $0
Net Income -$395K -$181K
Basic EPS $0.00 $0.00
Diluted EPS $0.00 $0.00
Basic Shares Outstanding 93.6M 91.7M
Diluted Shares Outstanding 93.6M 91.7M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Revenue $454K $389K $176K $179K $332K $118K $72K
Cost of Revenue $233K $203K $109K $230K $129K $92K $58K
Gross Profit $221K $186K $68K -$52K $203K $26K $14K
Research & Development $4.4K $0 -- -- $6.2K $25K --
Total Operating Expenses $260K $231K $219K $167K $124K $143K $125K
Operating Income -$39K -$45K -$152K -$219K $79K -$117K -$111K
EBITDA -$38K -$44K -$151K -$218K $80K -$115K -$110K
Interest Income -- $375 $375 -- -- $0 $0
Interest Expense $14K -$12K $11K $9.4K $9.1K $7.4K $5.7K
Income Before Tax -$53K -$56K -$163K -$226K $70K -$124K -$116K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0
Net Income -$53K -$56K -$163K -$226K $70K -$124K -$116K
Basic EPS $0.00 $0.00 $0.00 -- $0.00 $0.00 $0.00
Diluted EPS $0.00 $0.00 $0.00 -- $0.00 $0.00 $0.00
Basic Shares Outstanding 94.4M 94.4M 94.4M -- 91.2M 89.6M 95.9M
Diluted Shares Outstanding 94.4M 161.4M 94.4M -- 158.2M 89.6M 95.9M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents $79K $6.3K
Cash & Short-Term Investments $79K $6.3K
Accounts Receivable, Net $33K $0
Inventory $25K $207K
Total Current Assets $162K $258K
Property, Plant & Equipment, Net $31K $22K
Intangible Assets $0 $5.9K
Other Non-Current Assets $25K --
Total Non-Current Assets $433K $408K
Total Assets $595K $666K
Accounts Payable $2.4K $4.9K
Deferred Revenue (Current) $14K $0
Total Current Liabilities $745K $80K
Total Non-Current Liabilities $107K $561K
Total Liabilities $852K $641K
Total Debt (incl. Leases) $198K $261K
Retained Earnings -$15.97M -$15.58M
Total Stockholders' Equity -$258K $26K
Total Equity -$258K $26K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2024-12-31
Cash & Cash Equivalents $1.14M $128K $137K $79K $6.3K
Cash & Short-Term Investments $1.14M $128K $137K $79K $6.3K
Accounts Receivable, Net $53K $44K $79K $33K $0
Inventory $348K -- -- $25K $207K
Total Current Assets $1.56M $343K $359K $162K $258K
Property, Plant & Equipment, Net $42K $33K $35K $31K $22K
Intangible Assets -- -- -- $0 $5.9K
Other Non-Current Assets $30K -- -- $25K --
Total Non-Current Assets $889K $401K $418K $433K $408K
Total Assets $2.45M $744K $777K $595K $666K
Accounts Payable $23K $5.2K $28K $2.4K $4.9K
Deferred Revenue (Current) $140K $64K $218K $14K $0
Total Current Liabilities $1.44M $1.06M $1.11M $745K $80K
Total Non-Current Liabilities $47K $67K $87K $107K $561K
Total Liabilities $1.48M $1.12M $1.20M $852K $641K
Total Debt (incl. Leases) $139K $158K $178K $198K $261K
Retained Earnings -$16.25M -$16.10M -$16.14M -$15.97M -$15.58M
Total Stockholders' Equity $970K -$477K -$420K -$258K $26K
Total Equity $970K -$477K -$420K -$258K $26K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31
Net Income -$395K -$181K
Depreciation & Amortization $4.1K $433
Stock-Based Compensation $42K $31K
Change in Receivables -$33K $0
Change in Payables -$2.5K $4.9K
Operating Cash Flow -$179K -$335K
Capital Expenditure -$13K -$22K
Free Cash Flow -$192K -$357K
Investing Cash Flow -$32K -$26K
Common Stock Issued $70K $25K
Financing Cash Flow $284K $367K
Net Change in Cash $73K $5.8K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Net Income -$53K -$56K -$163K -$226K $70K -$124K -$116K
Depreciation & Amortization $1.6K $1.4K $1.3K $964 $1.3K $1.1K $774
Stock-Based Compensation $0 $0 $0 -- $0 $0 $0
Change in Receivables -$9.5K $35K -$46K $72K -$103K -$2.3K $0
Change in Payables $188K -$23K $26K -$132 -$471 $533 -$2.4K
Operating Cash Flow -$76K -$109K -$55K -$71K $59K -$136K -$31K
Capital Expenditure -$9.9K -$1 -$5.5K -$1 $0 -$13K $0
Free Cash Flow -$86K -$109K -$61K -$71K $59K -$150K -$31K
Investing Cash Flow -$9.9K -$5.3K -$5.5K $537 -$16K -$14K -$2.8K
Financing Cash Flow $1.10M $106K $118K -$4.4K -$4.3K $228K $65K
Net Change in Cash $1.01M -$8.6K $57K -$75K $39K $78K $31K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31
Gross Margin 27.4% 34.4%
Operating Margin -52.3% -2739.0%
Net Profit Margin -56.5% -2838.0%
Return on Equity (ROE) -- -709.0%
Return on Assets (ROA) -66.5% -27.2%
Current Ratio 0.22x 3.23x
Quick Ratio 0.18x 0.64x
Debt to Equity -- 10.22x
Revenue Growth (YoY) +10879.7% --
Gross Profit Growth (YoY) +8636.1% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Gross Margin 35.3% 37.7% 30.5% 27.4% -- -- --
Operating Margin -38.0% -31.3% -50.7% -52.3% -- -- --
Net Profit Margin -41.5% -34.8% -54.9% -56.5% -- -- --
Return on Equity (ROE) -51.3% -- -- -- -- -- --
Return on Assets (ROA) -20.3% -50.3% -56.9% -66.5% -- -- --
Current Ratio 1.09x 0.32x 0.32x 0.22x -- -- --
Quick Ratio 0.85x 0.16x 0.19x 0.18x -- -- --
Debt to Equity 0.14x -- -- -- -- -- --
Revenue Growth (YoY) +36.8% +228.9% +145.6% -- -- -- --
Gross Profit Growth (YoY) +8.6% +616.7% +380.9% -- -- -- --
Operating Income Growth (YoY) -149.4% -- -- -- -- -- --
Net Income Growth (YoY) -175.3% -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -228.0% -- -- -- -- -- --
Free Cash Flow Growth (YoY) -244.9% -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001160420) · from December 31, 2024 Data through September 30, 2026 · synced Nov 21, 2026, 05:06 UTC · Open in terminal